VV116
China approves homegrown oral antiviral for treating COVID-19
The Chinese company producing Azvudone claimed that 40% of COVID-19 patients administered the drug for more than a week during the third phase of the clinical trial showed improvements when it came to symptoms
- Brazil approves end to 6×1 work schedule and reduction of the work week to 40 hours
- Israel kills 31 people in Lebanon on the eve of Eid al-Adha
- Israel carries out sixth consecutive Eid massacre in Gaza
- Far-right Janez Janša to return for fourth government term in Slovenia
- With peace deal nearly final, US launches fresh attacks on Iran
